ATE136468T1 - Impfstoff zur behandlung von hsv - Google Patents
Impfstoff zur behandlung von hsvInfo
- Publication number
- ATE136468T1 ATE136468T1 AT87907206T AT87907206T ATE136468T1 AT E136468 T1 ATE136468 T1 AT E136468T1 AT 87907206 T AT87907206 T AT 87907206T AT 87907206 T AT87907206 T AT 87907206T AT E136468 T1 ATE136468 T1 AT E136468T1
- Authority
- AT
- Austria
- Prior art keywords
- hsv
- vaccine
- vaccines
- disease
- treatment
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000700584 Simplexvirus Species 0.000 abstract 7
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92121386A | 1986-10-20 | 1986-10-20 | |
US7960587A | 1987-07-29 | 1987-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE136468T1 true ATE136468T1 (de) | 1996-04-15 |
Family
ID=26762199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT87907206T ATE136468T1 (de) | 1986-10-20 | 1987-10-20 | Impfstoff zur behandlung von hsv |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0289550B1 (de) |
AT (1) | ATE136468T1 (de) |
CA (1) | CA1337395C (de) |
DE (1) | DE3751772T2 (de) |
HK (1) | HK148296A (de) |
WO (1) | WO1988002634A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5151267A (en) * | 1988-07-15 | 1992-09-29 | University Of Saskatchewan | Bovine herpesvirus type 1 polypeptides and vaccines |
US5585264A (en) * | 1988-07-15 | 1996-12-17 | University Of Saskatchewan | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides |
ATE123065T1 (de) * | 1989-07-07 | 1995-06-15 | Takeda Chemical Industries Ltd | Proteine und deren herstellung. |
EP0541692B1 (de) * | 1990-08-02 | 1999-05-06 | Chiron Corporation | Herpes simplex virus vp16 impfstoffe |
US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
US5585103A (en) * | 1991-07-25 | 1996-12-17 | Idec Pharmaceutical Corporation | Induction of cytotoxic T-lymphocyte responses |
US5709860A (en) * | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
US5679348A (en) * | 1992-02-03 | 1997-10-21 | Cedars-Sinai Medical Center | Immunotherapy for recurrent HSV infections |
GB9409962D0 (en) * | 1994-05-18 | 1994-07-06 | Smithkline Beecham Biolog | Novel compounds |
AU1273495A (en) * | 1994-12-06 | 1996-06-26 | Bruschettini S.R.L. | Glycoproteins from herpes virus and vaccines containing them |
GB2336367B (en) * | 1998-04-15 | 2002-03-27 | Johnson & Johnson Medical Ltd | Polyurethane foams for use in wound dressings |
EP2286792A1 (de) | 1999-02-26 | 2011-02-23 | Novartis Vaccines and Diagnostics, Inc. | Mikroemulsionen mit einer adsorbierenden Oberfläche, enthaltend eine Mikrotropfenemulsion |
JP2007505147A (ja) | 2003-09-12 | 2007-03-08 | アンティジェニクス インコーポレーテッド | 単純ヘルペスウイルス感染の治療および予防用ワクチン |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051120A (ja) * | 1983-08-31 | 1985-03-22 | Chemo Sero Therapeut Res Inst | 単純ヘルペスサブユニットワクチン |
US4642333A (en) * | 1983-09-16 | 1987-02-10 | Stanley Person | Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2 |
EP0628633B1 (de) * | 1984-04-06 | 2003-01-08 | Chiron Corporation | Rekombinanter Herpes Simplex gB-gD-Impfstoff |
-
1987
- 1987-10-20 EP EP87907206A patent/EP0289550B1/de not_active Expired - Lifetime
- 1987-10-20 WO PCT/US1987/002709 patent/WO1988002634A1/en active IP Right Grant
- 1987-10-20 AT AT87907206T patent/ATE136468T1/de not_active IP Right Cessation
- 1987-10-20 DE DE3751772T patent/DE3751772T2/de not_active Expired - Lifetime
- 1987-10-20 CA CA000549786A patent/CA1337395C/en not_active Expired - Lifetime
-
1996
- 1996-08-01 HK HK148296A patent/HK148296A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1988002634A1 (en) | 1988-04-21 |
DE3751772D1 (de) | 1996-05-15 |
EP0289550B1 (de) | 1996-04-10 |
EP0289550A4 (de) | 1989-12-28 |
DE3751772T2 (de) | 1996-12-05 |
HK148296A (en) | 1996-08-09 |
CA1337395C (en) | 1995-10-24 |
EP0289550A1 (de) | 1988-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE136468T1 (de) | Impfstoff zur behandlung von hsv | |
PT1296711E (pt) | E7 de vph para o tratamento do virus do papiloma humano | |
DE69535758D1 (de) | Lipid-analoge zur behandlung von viralen infektionen | |
PT83434B (pt) | Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida | |
PT93393A (pt) | Processo para a preparacao de vacinas e de agentes de diagnostico que contem regioes imunogenicas de proteina e7do virus do papiloma humano do tipo 16 ou anticorpos suscitados contra estas regioes | |
ATE475423T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen | |
RU93048466A (ru) | Применение бензотиофенов для профилактики и лечения остеопороза и фармацевтическая композиция на их основе | |
DE3684363D1 (de) | Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. | |
ATE219366T1 (de) | Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b | |
ATE101648T1 (de) | Expression eines tumorspezifischen antigens eines rekombinanten virusvektors sowie dessen anwendung zur versorgenden oder heilenden behandlung des entsprechenden tumors. | |
ATE165345T1 (de) | Sulfonsaeurederivate zur behandlung von viruserkrankungen | |
DE68906735D1 (de) | Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt. | |
ATE189394T1 (de) | Methode zur behandlung von viralen infektionen | |
DE68912155D1 (de) | Antivirales Kombinationspräparat. | |
AR005750A1 (es) | Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion | |
DE3767308D1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
ES2162862T3 (es) | Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon. | |
DE69010523D1 (de) | Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen. | |
ATE155795T1 (de) | Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier | |
DK384387D0 (da) | Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus | |
DK257887D0 (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
EA199700353A1 (ru) | Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции | |
ATE126704T1 (de) | Bcrf1-antagonisten zur behandlung von epstein- barr-virus-infektionen. | |
RU94038588A (ru) | Способ лечения вторичного иммунодефицита (вид) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |